RATING SCHEDULE · DC 7719

Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) · DC 7719

Compare the 4 rating levels listed for Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia) under DC 7719 and see which findings distinguish them.

This entry covers evaluation under DC 7719. A clinician establishes the diagnosis separately.

How is it connected to service?

The applicable direct, secondary, aggravation or presumptive route determines the service-connection evidence. Use the evidence guide to distinguish these routes.

Explore service-connection evidence →

What do the rating levels describe?

A diagnosis does not automatically establish a percentage. These are the source requirements for evaluating severity; related notes and exceptions still apply.

0%

The source describes this level as:

  • The requirements for a compensable evaluation are not met. A 0% evaluation may apply under §4.31.

30%

The source describes this level as:

  • In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors

60%

The source describes this level as:

  • Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission

100%

The source describes this level as:

  • Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment
Compare these levels with the original rating table

Find DC 7719 in the rating schedule

The highlighted row marks this code. Nearby rows provide context and can describe other conditions. Use the full schedule for applicable headings, footnotes and exceptions.

38 CFR Part 4 · excerpt surrounding DC 7719
Rating
Note (1): If the condition undergoes leukemic transformation, evaluate as leukemia under diagnostic code 7703.
Note (2): A 100 percent evaluation shall be assigned as of the date of hospital admission for peripheral blood or bone marrow stem cell transplant; or during the period of treatment with chemotherapy (including myelosuppressants) or interferon treatment. Six months following hospital discharge or, in the case of chemotherapy treatment, six months after completion of treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter.
7719 Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia):
Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment100
Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission60
In apparent remission on continuous molecularly targeted therapy with tyrosine kinase inhibitors30
Note (1): If the condition undergoes leukemic transformation, evaluate as leukemia under diagnostic code 7703
Note (2): A 100 percent evaluation shall be assigned as of the date of hospital admission for peripheral blood or bone marrow stem cell transplant; or during the period of treatment with chemotherapy (including myelosuppressants). Six months following hospital discharge or, in the case of chemotherapy treatment, six months after completion of treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105 of this chapter
7720 Iron deficiency anemia:
Related notes and evaluation rules

Note (1): If the condition undergoes leukemic transformation, evaluate as leukemia under diagnostic code 7703

Note (2): A 100 percent evaluation shall be assigned as of the date of hospital admission for peripheral blood or bone marrow stem cell transplant; or during the period of treatment with chemotherapy (including myelosuppressants). Six months following hospital discharge or, in the case of chemotherapy treatment, six months after completion of treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105 of this chapter

Official rating schedule · DC 7719, §4.117 ↗

Which evidence addresses the questions?

  • The documented diagnosis and applicable diagnostic code.
  • Clinical findings and functional effects addressing the applicable source criteria.
  • Timing, treatment and connection-to-service evidence for the applicable claim route.
How an independent medical review works →

Sources and scope

Guide source check: 2026-11-06. Rating-library snapshot: June 30, 2026. Source coverage is distinct from clinical review. This page does not diagnose, adjudicate a claim, or collect medical records.

Shared reference edition 1.2.4 · source check 2026-11-06. Coverage is stated for each framework and is distinct from clinical review. Rating-source snapshot: 2026-06-30.

About these educational tools

The calculator and guides provide general education, not medical, legal, or financial advice. Using them does not create a clinician-patient, evaluator-evaluee, or attorney-client relationship. Professional services require a separate accepted engagement.

VA determines eligibility, service connection, ratings, qualifying dependents, effective dates, and the amount payable. Using these tools does not submit a claim or appeal.

Diagnosis, connection to service, and severity are separate questions. Matching a description or screening score does not establish a diagnosis or entitlement. A qualified clinician should interpret medical findings. Do not change treatment based on these guides.

Ingleside Health is an independent physician service, not a law firm or VA-accredited claims representative. It is not affiliated with or endorsed by VA and does not prepare, present, prosecute, or file benefits claims.

Do not rely on an estimate alone for financial commitments or claim decisions. Check official VA information and seek appropriate individual advice.

Calculation assumptions and exclusions
  • Basic compensation estimate. Special Monthly Compensation (SMC), Total Disability based on Individual Unemployability (TDIU), offsets or recoupment, back pay, temporary total ratings, and unsupported adult-dependent categories are not calculated.
  • Bilateral handling covers the supported arm/leg selections. Other paired skeletal muscles, amputation limits, and overlapping manifestations need individual review. The tool cannot determine whether every entered rating may be separately combined.
  • Use separately established evaluations or clearly hypothetical percentages. Choosing a condition or percentage does not establish diagnosis, service connection, or entitlement.
  • Uses 2026 compensation rates effective December 1, 2025. Historical payments, future rate changes, and individual effective dates are not calculated. See the source dates on each reference; rules and rates may change.
Using the website or a chat tool

Calculator selections stay in this browser tab's memory and are not saved or submitted as intake. Refreshing the page resets the example. Do not enter personal records or identifiers. Website visits remain subject to the Website Privacy Policy.

Use hypothetical scenarios only in chat tools. Do not send records, identifiers, symptoms, or real case information. The chat provider's own terms and privacy settings apply; a chat conversation is not the Box-hosted clinical intake.

Accredited Veterans Service Organization (VSO) representatives provide free help with VA benefit claims. Find VA-accredited help. Read VA’s official rating guidance.

Terms of UseWebsite Privacy PolicyAccessibility and help

This business is not endorsed or sponsored by, or affiliated with, the United States Department of Veterans Affairs or the Illinois Department of Veterans Affairs, or any federally chartered VA accredited veteran service organization. You may qualify for other veterans benefits beyond the benefits for which you are receiving services here.

Veteran and military benefits services are available free of charge from VA accredited county veteran service officers, representatives of the Illinois Department of Veterans Affairs, and the veteran service officers of federally chartered veteran service organizations. To learn more, contact these organizations or the Illinois Attorney General's Office at 1-800-382-3000.